{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:10:31Z","timestamp":1788048631338,"version":"build-2784847793"},"reference-count":83,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.eprac.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T09:32:24Z","timestamp":1682242344000},"page":"670-677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Lipohypertrophy and Insulin: An Old Dog That Needs New Tricks"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3119-9361","authenticated-orcid":false,"given":"Jingtong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5592-453X","authenticated-orcid":false,"given":"Andrea M.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1335-1857","authenticated-orcid":false,"given":"David","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9059-6121","authenticated-orcid":false,"given":"Sandro","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-1304","authenticated-orcid":false,"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-9378","authenticated-orcid":false,"given":"Mohammed E.","family":"Al-Sofiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4945-2070","authenticated-orcid":false,"given":"Jeffrey I.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-4320","authenticated-orcid":false,"given":"Jane Jeffrie","family":"Seley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-6862","authenticated-orcid":false,"given":"David C.","family":"Klonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eprac.2023.04.006_bib1","doi-asserted-by":"crossref","first-page":"101635","DOI":"10.1016\/j.beem.2022.101635","article-title":"Endocrine immune-related adverse events: adrenal, parathyroid, diabetes insipidus, and lipoatrophy","volume":"36","author":"Atkinson","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2023.04.006_bib2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.mayocp.2016.06.010","article-title":"New insulin delivery recommendations","volume":"91","author":"Frid","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00592-017-1066-y","article-title":"Errors in insulin treatment management and risk of lipohypertrophy","volume":"55","author":"Pozzuoli","year":"2018","journal-title":"Acta Diabetol"},{"issue":"9","key":"10.1016\/j.eprac.2023.04.006_bib4","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s13300-020-00876-0","article-title":"Insulin-induced skin lipohypertrophy in type 2 diabetes: a multicenter regional survey in southern Italy","volume":"11","author":"Gentile","year":"2020","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4274\/jcrpe.galenos.2019.2019.0124","article-title":"Current diagnosis, treatment and clinical challenges in the management of lipodystrophy syndromes in children and young people","volume":"12","author":"\u00d6zen","year":"2020","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.eprac.2023.04.006_bib6","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.2147\/DMSO.S282926","article-title":"Prevalence, risk factors, and clinical characteristics of lipodystrophy in insulin-treated patients with diabetes: an old problem in a new era of modern insulin","volume":"13","author":"Thewjitcharoen","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"10.1016\/j.eprac.2023.04.006_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdi.12742","article-title":"Prevalence of lipohypertrophy in insulin-treated diabetes patients: a systematic review and meta-analysis","volume":"9","author":"Deng","year":"2017","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.eprac.2023.04.006_bib8","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.2147\/DMSO.S392324","article-title":"Gender differences in prevalence and clinical correlates of lipohypertrophy in insulin-exposed patients with diabetes mellitus","volume":"15","author":"Peng","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13300-016-0161-3","article-title":"Frequency of lipohypertrophy and associated risk factors in young patients with type 1 diabetes: a cross-sectional study","volume":"7","author":"Al Hayek","year":"2016","journal-title":"Diabetes Ther"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib10","doi-asserted-by":"crossref","first-page":"e20776","DOI":"10.5812\/ijem.20776","article-title":"Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus","volume":"13","author":"Al Ajlouni","year":"2015","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.eprac.2023.04.006_bib11","doi-asserted-by":"crossref","first-page":"9169296","DOI":"10.1155\/2022\/9169296","article-title":"Insulin-induced lipohypertrophy in patients with type 1 diabetes mellitus treated with an insulin pump","volume":"2022","author":"Ucieklak","year":"2022","journal-title":"Int J Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2023.04.006_bib12","first-page":"1087","article-title":"The impact of insulin-induced lipodystrophy on glycemic variability in pediatric patients with type 1 diabetes","volume":"9","author":"Lombardo","year":"2022","journal-title":"Children (Basel)"},{"issue":"3","key":"10.1016\/j.eprac.2023.04.006_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/1932296818759845","article-title":"Smart pens will improve insulin therapy","volume":"12","author":"Klonoff","year":"2018","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib14","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MJT.0000000000001097","article-title":"Insulin pump therapy","volume":"27","author":"Nimri","year":"2020","journal-title":"Am J Ther"},{"key":"10.1016\/j.eprac.2023.04.006_bib15","article-title":"Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes","author":"Korkmaz","year":"2021","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13300-020-00954-3","article-title":"Lipohypertrophy in elderly insulin-treated patients with type 2 diabetes","volume":"12","author":"Gentile","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.eprac.2023.04.006_bib17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3389\/fendo.2018.00638","article-title":"Insulin-related lipohypertrophy: lipogenic action or tissue trauma?","volume":"9","author":"Barola","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.eprac.2023.04.006_bib18","doi-asserted-by":"crossref","first-page":"738179","DOI":"10.3389\/fpubh.2021.738179","article-title":"A\u00a0systematic survey of physicians\u2019 insights into lipohypertrophy","volume":"9","author":"Shen","year":"2021","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.eprac.2023.04.006_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","article-title":"Lipodystrophy syndromes","volume":"45","author":"Hussain","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00128071-200708010-00003","article-title":"Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs","volume":"8","author":"Radermecker","year":"2007","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib21","first-page":"209","article-title":"Prevalence of lipohypertrophy and its associations in insulin-treated diabetic patients","volume":"39","author":"Nawaz","year":"2023","journal-title":"Pak J Med Sci"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","article-title":"Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes","volume":"39","author":"Blanco","year":"2013","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.eprac.2023.04.006_bib23","first-page":"4910962","article-title":"Effect of insulin-induced lipodystrophy on glycemic control among children and adolescents with diabetes in Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia","volume":"2018","author":"Tsadik","year":"2018","journal-title":"J\u00a0Diabetes Res"},{"issue":"4","key":"10.1016\/j.eprac.2023.04.006_bib24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.amjms.2016.01.008","article-title":"Influence of race, ethnicity and social determinants of health on diabetes outcomes","volume":"351","author":"Walker","year":"2016","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eprac.2022.11.008","article-title":"Evaluation of lipohypertrophy in patients with type 1 diabetes mellitus on multiple daily insulin injections or continuous subcutaneous insulin infusion","volume":"29","author":"Barlas","year":"2023","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12020-014-0195-0","article-title":"Impact of social determinants of health on outcomes for type 2 diabetes: a systematic review","volume":"47","author":"Walker","year":"2014","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.eprac.2023.04.006_bib27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/193229681000400332","article-title":"Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?","volume":"4","author":"Heinemann","year":"2010","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2023.04.006_bib28","article-title":"Assessment of insulin injection practice of nurses working in a tertiary healthcare center of Nepal","volume":"2018","author":"Adhikari","year":"2018","journal-title":"Nurs Res Pract"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.dsx.2018.11.042","article-title":"Why are so huge differences reported in the occurrence rate of skin lipohypertrophy? Does it depend on method defects or on lack of interest?","volume":"13","author":"Gentile","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib30","article-title":"Factors hindering correct identification of unapparent lipohypertrophy","volume":"3","author":"Gentile","year":"2016","journal-title":"J\u00a0Diabetes Metab Disord Control"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.17140\/DROJ-2-126","article-title":"Unexplained hypoglycaemia and large glycaemic variability: skin lipohypertrophy as a predictive sign","volume":"2","author":"Strollo","year":"2016","journal-title":"Diabetes Res Open J"},{"key":"10.1016\/j.eprac.2023.04.006_bib32","first-page":"1","article-title":"Why do so many people with type 2 diabetes who take insulin have lipohypertrophy? Fate or educational deficiencies?","volume":"6","author":"Gentile","year":"2022","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.eprac.2023.04.006_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.diabres.2017.01.020","article-title":"UK lipohypertrophy interventional study","volume":"126","author":"Smith","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"10.1016\/j.eprac.2023.04.006_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/dia.2017.0165","article-title":"An effective intervention for diabetic lipohypertrophy: results of a randomized, controlled, prospective multicenter study in France","volume":"19","author":"Campinos","year":"2017","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/dia.2004.6.698","article-title":"Measurement of insulin absorption and insulin action","volume":"6","author":"Heinemann","year":"2004","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"10.1016\/j.eprac.2023.04.006_bib36","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ccr3.2347","article-title":"Extent of lipohypertrophy in diabetic patients-sometimes much more than meets the eye","volume":"7","author":"Harsch","year":"2019","journal-title":"Clin Case Rep"},{"issue":"9","key":"10.1016\/j.eprac.2023.04.006_bib37","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc16-0610","article-title":"Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control","volume":"39","author":"Famulla","year":"2016","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1932296814538941","article-title":"Lipohypertrophy and the artificial pancreas: is this an issue?","volume":"8","author":"Heinemann","year":"2014","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.eprac.2023.04.006_bib39","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/jdi.13753","article-title":"Repeated insulin injection without site rotation affects skin thickness - ultrasonographic and histological evaluation","volume":"13","author":"Murao","year":"2022","journal-title":"J\u00a0Diabetes Investig"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13300-018-0561-7","article-title":"Impact of insulin injection and infusion routines on lipohypertrophy and glycemic control in children and adults with diabetes","volume":"10","author":"Deeb","year":"2019","journal-title":"Diabetes Ther"},{"issue":"3","key":"10.1016\/j.eprac.2023.04.006_bib41","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.xphs.2020.12.008","article-title":"Not the preservative m-cresol, instigates loss of infusion site patency over extended durations of CSII in diabetic swine","volume":"110","author":"Swinney","year":"2021","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.eprac.2023.04.006_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/dia.2017.0175","article-title":"Detailed analysis of insulin absorption variability and the tissue response to continuous subcutaneous insulin infusion catheter implantation in swine","volume":"19","author":"Hauzenberger","year":"2017","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.eprac.2023.04.006_bib43","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.xphs.2021.12.025","article-title":"Inflammation at site of insulin infusion diminishes glycemic control","volume":"111","author":"Kesserwan","year":"2022","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002553","article-title":"Characteristics and morphology of lipohypertrophic lesions in adults with type 1 diabetes with ultrasound screening: an exploratory observational study","volume":"9","author":"Hashem","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"10","key":"10.1016\/j.eprac.2023.04.006_bib45","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40618-017-0675-1","article-title":"Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus","volume":"40","author":"Bertuzzi","year":"2017","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"950","key":"10.1016\/j.eprac.2023.04.006_bib46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/pgmj.2004.019547","article-title":"Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control","volume":"80","author":"Wallymahmed","year":"2004","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/19322968221145731","article-title":"Advances in insulin infusion set in the new era of automated insulin delivery: a systematic review","volume":"17","author":"Zhang","year":"2023","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2016-000266","article-title":"Pen needle design influences ease of insertion, pain, and skin trauma in subjects with type 2 diabetes","volume":"4","author":"Pr\u00e6stmark","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib49","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/19322968211059564","article-title":"Needle technology for insulin administration: a century of innovation","volume":"17","author":"Heinemann","year":"2023","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/193229681200600216","article-title":"Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes","volume":"6","author":"Hirsch","year":"2012","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib51","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41598-017-18790-0","article-title":"Systematic in vivo evaluation of the time-dependent inflammatory response to steel and Teflon insulin infusion catheters","volume":"8","author":"Hauzenberger","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000881","article-title":"In vivo investigation of the tissue response to commercial teflon insulin infusion sets in large swine for 14 days: the effect of angle of insertion on tissue histology and insulin spread within the subcutaneous tissue","volume":"7","author":"Eisler","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.eprac.2023.04.006_bib53","article-title":"In vivo study of the inflammatory tissue\u00a0response surrounding a novel extended-wear kink-resistant insulin\u00a0infusion set prototype compared with a commercial control over two weeks of wear time","author":"Kastner","year":"2022","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.eprac.2023.04.006_bib54","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/dia.2021.0540","article-title":"Evaluation of extended infusion set performance in adults with type 1 diabetes: infusion set survival rate and glycemic outcomes from a pivotal trial","volume":"24","author":"Brazg","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.eprac.2023.04.006_bib55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/dia.2015.0432","article-title":"Duration of infusion set survival in lipohypertrophy versus nonlipohypertrophied tissue in patients with type 1 diabetes","volume":"18","author":"Karlin","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib56","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s13300-021-01006-0","article-title":"Role of structured education in reducing lypodistrophy and its metabolic complications in insulin-treated people with type 2 diabetes: a randomized multicenter case-control study","volume":"12","author":"Gentile","year":"2021","journal-title":"Diabetes Ther"},{"issue":"9","key":"10.1016\/j.eprac.2023.04.006_bib57","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1007\/s13300-021-01108-9","article-title":"The durability of an intensive, structured education-based rehabilitation protocol for best insulin injection practice: the ISTERP-2 study","volume":"12","author":"Gentile","year":"2021","journal-title":"Diabetes Ther"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib58","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s12325-022-02105-5","article-title":"The economic burden of insulin injection-induced lipohypertophy. Role of education: the ISTERP-3 study","volume":"39","author":"Gentile","year":"2022","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib59","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/1932296819888213","article-title":"Lipohypertrophy effect on glycemic profile in an adult with type 1 diabetes using scanned continuous glucose monitoring","volume":"14","author":"Oriot","year":"2020","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib60","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/1932296820950688","article-title":"A\u00a0new medical device for improved rotation of insulin injections in type 1 diabetes mellitus: a proof-of-concept study","volume":"15","author":"Klarskov","year":"2021","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.17140\/DROJ-8-156","article-title":"Why 100-years after the discovery of insulin and the appearance of insulin-induced lipodystrophy: are we still struggling with this nasty complication?","volume":"8","author":"Gentile","year":"2022","journal-title":"Diabetes Res Open J"},{"key":"10.1016\/j.eprac.2023.04.006_bib62","author":"Scaramuzza"},{"issue":"3","key":"10.1016\/j.eprac.2023.04.006_bib63","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.eprac.2022.12.015","article-title":"Type 1 diabetes mellitus and lipohypertrophy - impact of the intervention on glycemic control via patient\u2019s examination and retraining on change of infusion set","volume":"29","author":"Ucieklak","year":"2023","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib64","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s40064-016-1978-y","article-title":"A\u00a0suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes","volume":"5","author":"Gentile","year":"2016","journal-title":"SpringerPlus"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib65","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s13300-018-0472-7","article-title":"A\u00a0systematic review of ultrasound-detected lipohypertrophy in insulin-exposed people with diabetes","volume":"9","author":"Abu Ghazaleh","year":"2018","journal-title":"Diabetes Ther"},{"issue":"29","key":"10.1016\/j.eprac.2023.04.006_bib66","doi-asserted-by":"crossref","first-page":"e26743","DOI":"10.1097\/MD.0000000000026743","article-title":"Values of ultrasound for diagnosis and management of insulin-induced lipohypertrophy: a prospective cohort study in China","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.eprac.2023.04.006_bib67","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/dme.13764","article-title":"Ultrasound detection of insulin-induced lipohypertrophy in type 1 and type 2 diabetes","volume":"35","author":"Kapeluto","year":"2018","journal-title":"Diabet Med"},{"issue":"9475","key":"10.1016\/j.eprac.2023.04.006_bib68","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(05)66668-8","article-title":"As fit as a butcher\u2019s dog","volume":"365","author":"Kerr","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib69","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13410-020-00889-2","article-title":"Lipohypertrophy in insulin injecting patients with diabetes mellitus: an under-recognized barrier for glycemic control","volume":"41","author":"Kumar","year":"2021","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13300-022-01332-x","article-title":"Addendum 1: forum for injection technique and therapy expert recommendations, India","volume":"14","author":"Kalra","year":"2023","journal-title":"Diabetes Ther"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib71","doi-asserted-by":"crossref","first-page":"e34830","DOI":"10.2196\/34830","article-title":"Machine learning decision support for detecting lipohypertrophy with bedside ultrasound: proof-of-concept study","volume":"6","author":"Bandari","year":"2022","journal-title":"JMIR Form Res"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib72","first-page":"104","article-title":"Ultrasonographic aspect of subcutaneous tissue dystrophies as a result of insulin injections","volume":"12","author":"Perciun","year":"2010","journal-title":"Med Ultrason"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.14341\/DM12095","article-title":"Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention","volume":"23","author":"Klimontov","year":"2020","journal-title":"Diabetes mellitus"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.26.1.89","article-title":"Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes","volume":"26","author":"Fineberg","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13601-018-0223-x","article-title":"Insulin allergy can be\u00a0successfully managed by a systematic approach","volume":"8","author":"Haastrup","year":"2018","journal-title":"Clin Transl Allergy"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib76","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/dmrr.714","article-title":"Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues","volume":"23","author":"Radermecker","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.eprac.2023.04.006_bib77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1398-9995.2007.01567.x","article-title":"Insulin allergy: clinical manifestations and management strategies","volume":"63","author":"Heinzerling","year":"2008","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.eprac.2023.04.006_bib78","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/diacare.25.5.876","article-title":"Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes","volume":"25","author":"Lindholm","year":"2002","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2023.04.006_bib79","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2337\/diab.45.12.1750","article-title":"Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin","volume":"45","author":"Fineberg","year":"1996","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.eprac.2023.04.006_bib80","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2337\/diab.39.6.728","article-title":"Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates","volume":"39","author":"Ratner","year":"1990","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.eprac.2023.04.006_bib81","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMc0808282","article-title":"Rituximab and omalizumab in severe, refractory insulin allergy","volume":"360","author":"Yong","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.eprac.2023.04.006_bib82","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.prp.2017.08.013","article-title":"Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis","volume":"213","author":"Ansari","year":"2017","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.eprac.2023.04.006_bib83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00256-017-2749-8","article-title":"Imaging characteristics of subcutaneous amyloid deposits in diabetic patients: the \u201cinsulin ball.\u201d","volume":"47","author":"Tanio","year":"2018","journal-title":"Skeletal Radiol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23003865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23003865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:14:35Z","timestamp":1761516875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23003865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":83,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1530891X23003865"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.04.006","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipohypertrophy and Insulin: An Old Dog That Needs New Tricks","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}